PREVALENCE OF PERIPHERAL NEUROPATHY SECONDARY TO CHEMOTHERAPY IN WOMEN WITH BREAST CANCER

Authors

  • Victor Domingos Lisita Rosa Universidade Federal de Goiás
  • Amanda Laíza dos Reis Mota Universidade Federal de Goiás
  • Diego Vinícius Gonçalves Santana Universidade Federal de Goiás
  • Lanuscia Morais de Santana Universidade Federal de Goiás
  • Beatriz Rocha Almeida Universidade Federal de Goiás
  • Hugo Francisco da Fonseca Neto Universidade Federal de Goiás
  • Lucas Pierson Brom Vieira Universidade Federal de Goiás
  • Ruffo de Freitas-Junior Universidade Federal de Goiás

Keywords:

Breast Cancer, Neuropathy, Chemotherapy

Abstract

Objective: This study aims to assess the prevalence of peripheral neuropathy in patients undergoing potentially neurotoxic chemotherapy for breast cancer. Methodology: This is a longitudinal study to assess the prevalence of peripheral neuropathy in women with breast cancer undergoing chemotherapy at the Hospital das Clínicas, Universidade Federal de Goiás (HC-UFG). The study was approved by the Ethics and Research Committee of HC-UFG, and all participants signed an informed consent form. For the data collection, two instruments were used, namely, Sociodemographic Form and Antineoplastic-Induced Neurotoxicity Questionnaire (AINQ). The Microsoft® Excel 2007 was used to tabulate the data, and the statistical analysis was performed using the SPSS® for Windows® program, version 22.0. Results: A total of 30 patients were included in this study. The average age was 51.2 years, and the sociodemographic evaluation showed that the majority of the participants were married (60%), 46.7% had one or two children, 23.3% were unemployed, and the schooling time was 9.88 years. As for the analysis of the AINQ in the three moments of the study, there was no statistical difference between the use of chemotherapy, body mass index, and age for a higher incidence of symptoms of peripheral neuropathy. The prevalence of symptoms of peripheral neuropathy in the sample was 83.3%, with orofacial symptoms being the most reported (grades 1 and 2). Conclusion: The study confirmed the high prevalence of neurotoxicity symptoms related to chemotherapy, both acute and chronic. The persistence of chronic symptoms suggests that, if chemotherapy- induced peripheral neuropathy (CIPN) is correctly diagnosed, it will be possible to control it early, avoiding further damage to patients.

Downloads

Download data is not yet available.

Downloads

Published

2021-10-14

How to Cite

Rosa, V. D. L., Mota, A. L. dos R., Santana, D. V. G., Santana, L. M. de, Almeida, B. R., Fonseca Neto, H. F. da, … Freitas-Junior, R. de. (2021). PREVALENCE OF PERIPHERAL NEUROPATHY SECONDARY TO CHEMOTHERAPY IN WOMEN WITH BREAST CANCER. Mastology, 31, 88. Retrieved from https://revistamastology.emnuvens.com.br/revista/article/view/1061

Issue

Section

E-poster